DNAprint Genomics (DNAG)

[chiggah]

Gandolf,
Please review the first news articles about M2Gen. I think there is mention of Merck keeping contracts and associations secret for now. It would only be typical taking into consideration competitive factors. Even though a Merck/DNAPrint association may be newsworthy and comforting to shareholders, it still only means revenues down the road, and DNAPrint has many other irons in the fire that equal or outweigh such an association.

If DNAPrint can save Pharms 100's of millions by cutting the time of drug-to-market, they will be in the driver's seat. Maybe this is why Merck wants associations kept quiet right now.